vs

Side-by-side financial comparison of California Resources Corp (CRC) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $119.0M, roughly 1.2× California Resources Corp). Oncology Institute, Inc. produced more free cash flow last quarter ($2.2M vs $-32.0M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs -46.3%).

California Resources Corporation is an American energy corporation engaged in hydrocarbon exploration in California. It is organized in Delaware and headquartered in Long Beach, California. Its mineral acreage holdings in California constitute the largest privately held position in the state.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

CRC vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.2× larger
TOI
$142.0M
$119.0M
CRC
More free cash flow
TOI
TOI
$34.2M more FCF
TOI
$2.2M
$-32.0M
CRC
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
-46.3%
CRC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CRC
CRC
TOI
TOI
Revenue
$119.0M
$142.0M
Net Profit
$-7.5M
Gross Margin
Operating Margin
-597.5%
-4.9%
Net Margin
-5.3%
Revenue YoY
41.6%
Net Profit YoY
43.0%
EPS (diluted)
$-8.02
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRC
CRC
TOI
TOI
Q1 26
$119.0M
Q4 25
$679.0M
$142.0M
Q3 25
$715.0M
$136.6M
Q2 25
$702.0M
$119.8M
Q1 25
$814.0M
$104.4M
Q4 24
$826.0M
$100.3M
Q3 24
$870.0M
$99.9M
Q2 24
$412.0M
$98.6M
Net Profit
CRC
CRC
TOI
TOI
Q1 26
Q4 25
$12.0M
$-7.5M
Q3 25
$64.0M
$-16.5M
Q2 25
$172.0M
$-17.0M
Q1 25
$115.0M
$-19.6M
Q4 24
$33.0M
$-13.2M
Q3 24
$345.0M
$-16.1M
Q2 24
$8.0M
$-15.5M
Operating Margin
CRC
CRC
TOI
TOI
Q1 26
-597.5%
Q4 25
6.9%
-4.9%
Q3 25
13.7%
-5.9%
Q2 25
38.0%
-9.4%
Q1 25
22.9%
-9.5%
Q4 24
8.2%
-11.9%
Q3 24
59.5%
-13.9%
Q2 24
9.2%
-16.6%
Net Margin
CRC
CRC
TOI
TOI
Q1 26
Q4 25
1.8%
-5.3%
Q3 25
9.0%
-12.1%
Q2 25
24.5%
-14.2%
Q1 25
14.1%
-18.8%
Q4 24
4.0%
-13.1%
Q3 24
39.7%
-16.1%
Q2 24
1.9%
-15.7%
EPS (diluted)
CRC
CRC
TOI
TOI
Q1 26
$-8.02
Q4 25
$0.21
$-0.04
Q3 25
$0.76
$-0.14
Q2 25
$1.92
$-0.15
Q1 25
$1.26
$-0.21
Q4 24
$0.87
$-0.14
Q3 24
$3.78
$-0.18
Q2 24
$0.11
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRC
CRC
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
Stockholders' EquityBook value
$2.9B
$-15.7M
Total Assets
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRC
CRC
TOI
TOI
Q1 26
Q4 25
$132.0M
Q3 25
$196.0M
Q2 25
$72.0M
Q1 25
$214.0M
Q4 24
$372.0M
Q3 24
$241.0M
Q2 24
$1.0B
$9.9M
Total Debt
CRC
CRC
TOI
TOI
Q1 26
Q4 25
Q3 25
$1.0B
Q2 25
$1.0B
Q1 25
$1.0B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.2B
Stockholders' Equity
CRC
CRC
TOI
TOI
Q1 26
$2.9B
Q4 25
$3.7B
$-15.7M
Q3 25
$3.4B
$-12.3M
Q2 25
$3.4B
$-9.0M
Q1 25
$3.5B
$5.1M
Q4 24
$3.5B
$3.6M
Q3 24
$3.5B
$15.5M
Q2 24
$2.1B
$29.2M
Total Assets
CRC
CRC
TOI
TOI
Q1 26
Q4 25
$7.4B
$164.7M
Q3 25
$6.8B
$163.6M
Q2 25
$6.7B
$159.8M
Q1 25
$6.8B
$164.0M
Q4 24
$7.1B
$172.7M
Q3 24
$7.1B
$179.2M
Q2 24
$4.5B
$179.6M
Debt / Equity
CRC
CRC
TOI
TOI
Q1 26
Q4 25
Q3 25
0.29×
Q2 25
0.30×
Q1 25
0.29×
Q4 24
0.32×
Q3 24
0.32×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRC
CRC
TOI
TOI
Operating Cash FlowLast quarter
$99.0M
$3.2M
Free Cash FlowOCF − Capex
$-32.0M
$2.2M
FCF MarginFCF / Revenue
-26.9%
1.5%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$380.0M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRC
CRC
TOI
TOI
Q1 26
$99.0M
Q4 25
$235.0M
$3.2M
Q3 25
$279.0M
$-12.6M
Q2 25
$165.0M
$-10.2M
Q1 25
$186.0M
$-5.0M
Q4 24
$206.0M
$4.2M
Q3 24
$220.0M
$819.0K
Q2 24
$97.0M
$-15.7M
Free Cash Flow
CRC
CRC
TOI
TOI
Q1 26
$-32.0M
Q4 25
$115.0M
$2.2M
Q3 25
$188.0M
$-13.2M
Q2 25
$109.0M
$-11.4M
Q1 25
$131.0M
$-5.3M
Q4 24
$118.0M
$2.4M
Q3 24
$141.0M
$417.0K
Q2 24
$63.0M
$-17.5M
FCF Margin
CRC
CRC
TOI
TOI
Q1 26
-26.9%
Q4 25
16.9%
1.5%
Q3 25
26.3%
-9.7%
Q2 25
15.5%
-9.5%
Q1 25
16.1%
-5.1%
Q4 24
14.3%
2.4%
Q3 24
16.2%
0.4%
Q2 24
15.3%
-17.7%
Capex Intensity
CRC
CRC
TOI
TOI
Q1 26
Q4 25
17.7%
0.7%
Q3 25
12.7%
0.4%
Q2 25
8.0%
1.0%
Q1 25
6.8%
0.3%
Q4 24
10.7%
1.8%
Q3 24
9.1%
0.4%
Q2 24
8.3%
1.9%
Cash Conversion
CRC
CRC
TOI
TOI
Q1 26
Q4 25
19.58×
Q3 25
4.36×
Q2 25
0.96×
Q1 25
1.62×
Q4 24
6.24×
Q3 24
0.64×
Q2 24
12.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRC
CRC

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons